These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 16771788)
1. Sublingual immunotherapy in children. Re: Marcucci et al. de Bot C; Moed H; van der Wouden JC Pediatr Allergy Immunol; 2006 Jun; 17(4):315; author reply 316-7. PubMed ID: 16771788 [No Abstract] [Full Text] [Related]
2. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Tahamiler R; Saritzali G; Canakcioglu S Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861 [TBL] [Abstract][Full Text] [Related]
5. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis. Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573 [TBL] [Abstract][Full Text] [Related]
8. Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands. Marogna M; Massolo A; Colombo F; Isella P; Bruno M; Falagiani P Allergol Immunopathol (Madr); 2011; 39(2):60-7. PubMed ID: 21216083 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800 [TBL] [Abstract][Full Text] [Related]
10. Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma. Majak P; Rychlik B; Pułaski L; Błauz A; Agnieszka B; Bobrowska-Korzeniowska M; Kuna P; Stelmach I J Allergy Clin Immunol; 2010 Jun; 125(6):1220-7. PubMed ID: 20434204 [TBL] [Abstract][Full Text] [Related]
11. Adherence to sublingual immunotherapy in preschool children. Pajno GB; Caminiti L; Crisafulli G; Barberi S; Landi M; Aversa T; Valenzise M; Passalacqua G Pediatr Allergy Immunol; 2012 Nov; 23(7):688-9. PubMed ID: 22985448 [No Abstract] [Full Text] [Related]
14. Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum. Malling HJ Dan Med Bull; 1990 Feb; 37(1):12-22. PubMed ID: 2178885 [No Abstract] [Full Text] [Related]
15. [Are there specific treatments for allergic asthma?]. Didier A; De Blay F; Tetu L; Dubus JC; Grimfeld A; Just J; Demoly P Rev Mal Respir; 2007 Oct; 24(8 Pt 3):7S41-51. PubMed ID: 18033202 [No Abstract] [Full Text] [Related]